Loading...

Advertisement

Becton, Dickinson Boosts FY23 Outlook - Update

RTTNews | 678 days ago

Becton, Dickinson Boosts FY23 Outlook - Update

(RTTNews) - While reporting financial results for the second quarter on Thursday, medical technology company Becton, Dickinson and Co. (BDX) raised its adjusted earnings and revenue outlook for fiscal 2023.

For fiscal 2023, the company now projects adjusted earnings in a range of $12.10 to $12.32 per share on revenues between approximately $19.2 billion to $19.3 billion, with currency-neutral revenue growth of 6.5 to 7.0 percent.

Previously, the company expected adjusted earnings in a range of $12.07 to $12.32 per share on revenues between approximately $19.1 billion to $19.3 billion, with currency-neutral revenue growth of 5.75 to 6.75 percent.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $12.21 per share on revenue growth of 1.9 percent to $19.22 billion for the year. Analysts' estimates typically exclude special items.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Tags: BDX

read more

BD Recalls ChloraPrep Clear 1 ML Applicators

BD Recalls ChloraPrep Clear 1 ML Applicators

Medical technology company Becton, Dickinson and Co. or BD has recalled one lot of ChloraPrep Clear 1 mL Applicators citing potential fungal contamination, the U.S. Food and Drug Administration said. Under certain environmental conditions, the contamination allows the growth of Aspergillus penicillioides within the packaging.

RTTNews | 21 days ago

Becton, Dickinson Boosts FY24 Ad, EPS Outlook - Update

Becton, Dickinson Boosts FY24 Ad, EPS Outlook - Update

While reporting financial results for the third quarter on Thursday, medical technology company Becton, Dickinson and Co. (BDX) raised its adjusted earnings guidance for fiscal 2024, while trimming annual revenue outlook.

RTTNews | 223 days ago

BD Announces Global Commercial Release Of New BD FACSDiscover S8 Cell Sorters

BD Announces Global Commercial Release Of New BD FACSDiscover S8 Cell Sorters

Medical technology company BD or Becton, Dickinson and Co. (BDX) announced Friday the global commercial release of new cell sorters that will enable more researchers in a broader range of fields, including cell biology, cancer research and immunology, to reveal insights that were previously invisible in traditional flow cytometry experiments.

RTTNews | 341 days ago

BD Gets FDA 510(k) Clearance For Fingertip Blood Collection Device

BD Gets FDA 510(k) Clearance For Fingertip Blood Collection Device

Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Thursday it has received 510(k) clearances from the U.S. Federal Drug Administration (FDA) for a novel blood collection device that obtains blood samples from a fingerstick that produce lab-quality results for some of the most commonly ordered blood tests.

RTTNews | 461 days ago

BD To Sell Surgical Instrumentation Platform To STERIS For $540 Mln

BD To Sell Surgical Instrumentation Platform To STERIS For $540 Mln

Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Tuesday that it has signed a definitive agreement to sell its Surgical Instrumentation platform to STERIS plc (STE) for $540 million.

RTTNews | 631 days ago

Becton, Dickinson Boosts FY23 Outlook - Update

Becton, Dickinson Boosts FY23 Outlook - Update

While reporting financial results for the first quarter on Thursday, medical technology company Becton, Dickinson and Co. or BD (BDX) raised its adjusted earnings and revenue outlook for fiscal 2023.

RTTNews | 769 days ago

Becton, Dickinson Guides FY23 Below Estimates; Boosts Dividend 4.6% - Update

Becton, Dickinson Guides FY23 Below Estimates; Boosts Dividend 4.6% - Update

While reporting financial results for the fourth quarter on Thursday, medical technology company Becton, Dickinson and Co. or BD (BDX) initiated its adjusted earnings and revenue outlook for fiscal 2023.

RTTNews | 853 days ago

Singapore Stock Market May Find Additional Support On Thursday

Singapore Stock Market May Find Additional Support On Thursday

The Singapore stock market on Wednesday snapped the three-day losing streak in which it had dropped almost 100 points or 2.5 percent. The Straits Time Index now sits just above the 3,830-point plateau and it may add to its winnings on Thursday.

RTTNews | 4h 10min ago

Terms | Privacy | Site Map | Site Map Calendar

© 2025 Myfxbook Ltd. All Rights Reserved.

HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.